The market has significant growth opportunities owing to growing potential applications of heparin ranging from anti-inflammatory and anti-tumor applications to prevention of infectious disease and use as nano-carriers for drug delivery. However, the wide availability of alternative anticoagulants such as warfarin, coumarins, and oral anticoagulants are expected to hamper heparin sales, thereby negatively impacting market growth.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
